Literature DB >> 11270917

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

M Kubera1, A H Lin, G Kenis, E Bosmans, D van Bockstaele, M Maes.   

Abstract

There is some evidence that major depression--in particular, treatment-resistant depression (TRD)--is accompanied by activation of the inflammatory response system and that proinflammatory cytokines may play a role in the etiology of depression. This study was carried out to examine the effects of antidepressive agents, i.e., imipramine, venlafaxine, L-5-hydroxytryptophan, and fluoxetine on the production of interferon-gamma (IFN-gamma), a proinflammatory cytokine, and interleukin-10 (IL-10), a negative immunoregulatory cytokine. Diluted whole blood of fluoxetine-treated patients with TRD (mean age, 50.6+/-3.9 years) and age-matched healthy controls (mean age, 51.6+/-1.7 years) and younger healthy volunteers (mean age, 35.4+/-9.6 years) was stimulated with phytohemagglutinin (1 microg/mL) and lipopolysaccharide (5 microg/mL) for 48 hours with and without incubation with the antidepressants at 10-6 M and 10(-5) M. IFN-gamma and IL-10 were quantified by means of enzyme-linked immunoassays. The ratio of IFN-gamma to IL-10 production by immunocytes was computed because this ratio is of critical importance in determining the capacity of immunocytes to activate or inhibit monocytic and T-lymphocytic functions. All four antidepressive drugs significantly increased the production of IL-10. Fluoxetine significantly decreased the production of IFN-gamma. All four antidepressants significantly reduced the IFN-gamma/IL-10 ratio. There were no significant differences in the antidepressant-induced changes in IFN-gamma or IL-10 between younger and older healthy volunteers and TRD patients. Tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin-noradrenaline reuptake inhibitors, as well as the immediate precursor of serotonin, have a common, negative immunoregulatory effect by suppressing the IFN-gamma/IL-10 production ratio. It is suggested that the therapeutic efficacy of antidepressants may be related to their negative immunoregulatory effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270917     DOI: 10.1097/00004714-200104000-00012

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  86 in total

Review 1.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

Review 2.  Neurobiology of resilience in depression: immune and vascular insights from human and animal studies.

Authors:  Katarzyna A Dudek; Laurence Dion-Albert; Fernanda Neutzling Kaufmann; Ellen Tuck; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2019-09-13       Impact factor: 3.386

3.  Immune system dysregulation in adolescent major depressive disorder.

Authors:  Vilma Gabbay; Rachel G Klein; Carmen M Alonso; James S Babb; Melissa Nishawala; Georgette De Jesus; Glenn S Hirsch; Pauline M Z Hottinger-Blanc; Charles J Gonzalez
Journal:  J Affect Disord       Date:  2008-09-13       Impact factor: 4.839

4.  Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages.

Authors:  Katarzyna Nazimek; Michael Kozlowski; Pawel Bryniarski; Spencer Strobel; Agata Bryk; Michal Myszka; Anna Tyszka; Piotr Kuszmiersz; Jaroslaw Nowakowski; Iwona Filipczak-Bryniarska
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-05

5.  Cytokine regulation of tryptophan metabolism in the hypothalamic-pituitary-adrenal (HPA) axis: implications for protective and toxic consequences in neuroendocrine regulation.

Authors:  Huolin Tu; Peter L Rady; Terry Juelich; Eric M Smith; Stephen K Tyring; Thomas K Hughes
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

6.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.

Authors:  Firoza Mamdani; Marcelo T Berlim; Marie-Martine Beaulieu; Gustavo Turecki
Journal:  World J Biol Psychiatry       Date:  2013-03-26       Impact factor: 4.132

7.  Effects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depression.

Authors:  Zhen-Hua Chen; Ling Xiao; Ji-Hong Chen; He-Shen Luo; Gao-Hua Wang; Yong-Lan Huang; Xiao-Ping Wang
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  The changing microbial environment and chronic inflammatory disorders.

Authors:  Graham Aw Rook
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

9.  Effect of venlafaxine on bone loss associated with ligature-induced periodontitis in Wistar rats.

Authors:  Rosimary S Carvalho; Carolina M de Souza; Julliana C S Neves; Sergio A Holanda-Pinto; Lívia M S Pinto; Gerly A C Brito; Geanne M de Andrade
Journal:  J Negat Results Biomed       Date:  2010-06-14

10.  Interleukin-10: a key cytokine in depression?

Authors:  Susana Roque; Margarida Correia-Neves; Ana Raquel Mesquita; Joana Almeida Palha; Nuno Sousa
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.